Related Experiment Video
Updated: Sep 29, 2025
08:43
Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
7.7K
A regulatory perspective on recombinant collagen-based medical devices
Wenbo Liu1, Hai Lin2, Peng Zhao1
1Center for Medical Device Evaluation, National Medical Products Administration, Beijing, China.
Bioactive Materials
|March 21, 2022
Summary
Recombinant collagens, novel biomaterials from synthetic biology, show promise for medical devices. Regulatory science is crucial for evaluating their safety and efficacy for clinical use.
Area of Science:
- Biomaterials Science
- Regulatory Science
- Synthetic Biology
Background:
- Recombinant collagens are novel biomaterials produced using synthetic biology.
- They are being explored for diverse medical applications.
- A regulatory perspective is essential for their clinical translation.
Purpose of the Study:
- To present a regulatory scientific perspective on recombinant collagens and their medical devices.
- To outline their definition, translation, classification, and technical review processes.
- To highlight the role of regulatory science in ensuring safety and efficacy.
Main Methods:
- Categorization of recombinant collagens based on composition and structure (recombinant human collagen, humanized collagen, collagen-like protein).
- Classification of recombinant collagen-based medical devices (Class II or III in China) based on risk and intended use.
- Assessment of safety and efficacy through preclinical and clinical evaluations.
Main Results:
- Recombinant collagens are classified into distinct types.
- Medical devices utilizing these collagens fall under specific risk classes in China.
- Regulatory review focuses on scientific evidence from rigorous evaluations.
Conclusions:
- Recombinant collagen-based medical devices present both opportunities and challenges for clinical application.
- Regulatory science provides essential frameworks, standards, and methods for evaluating these products.
- Ensuring safety and efficacy through robust regulatory oversight is paramount for successful clinical translation.
